Table 3.
Associations between dialkyl phosphate metabolite concentrations during pregnancy and cord blood thyroid hormone concentrations
| Mean TSH | Mean FT4 | |||
|---|---|---|---|---|
| Dialkyl phosphates | β (95% CI) | p | β (95% CI) | p |
| Average concentrations during pregnancy | ||||
| Total dialkyl phosphates | ||||
| Model 1 | −0.07 (−0.17 to 0.03) | 0.15 | 0.12 (−1.47 to 1.70) | 0.88 |
| Model 2 | −0.07 (−0.18 to 0.03) | 0.16 | 0.27 (−1.37 to 1.91) | 0.75 |
| Dimethyl alkyl phosphates | ||||
| Model 1 | −0.08 (−0.17 to 0.02) | 0.13 | 0.04 (−1.48 to 1.56) | 0.96 |
| Model 2 | −0.07 (−0.17 to 0.03) | 0.15 | 0.15 (−1.41 to 1.72) | 0.85 |
| Diethyl alkyl phosphates | ||||
| Model 1 | −0.02 (−0.10 to 0.06) | 0.64 | 0.28 (−1.00 to 1.56) | 0.67 |
| Model 2 | −0.03 (−0.11 to 0.05) | 0.45 | 0.39 (−0.94 to 1.72) | 0.56 |
Average dialkyl phosphate metabolite concentrations (nmol/g creatinine) were computed by the geometric mean of the three urine collection phases.
All dialkyl phosphate metabolite concentrations and TSH values were log transformed.
N= 472 for TSH and n=477 for FT4.
Model 1 was adjusted for gestational age at blood sampling.
Model 2 was additionally adjusted for maternal age, parity, smoking and ethnicity, and child sex.